Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review

ML Cutress, GD Stewart, P Zakikhani… - BJU …, 2012 - Wiley Online Library
What's known on the subject? and What does the study add? Endoscopic management of
upper tract urothelial carcinoma (UTUC) using either ureteroscopy and laser ablation, or …

Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature

B Foerster, D D'Andrea, M Abufaraj… - … Oncology: Seminars and …, 2019 - Elsevier
Purpose: To assess the oncologic impact of adjuvant endocavitary instillation after kidney-
sparing surgery (KSS) in the treatment of upper tract urothelial carcinoma (UTUC). Methods …

Optimal management of upper tract urothelial carcinoma: current perspectives

JJ Leow, Z Liu, TW Tan, YM Lee, EK Yeo… - OncoTargets and …, 2020 - Taylor & Francis
Introduction Upper tract urothelial carcinoma (UTUC) is a relatively uncommon urologic
malignancy for which there has not been significant improvement in survival over the past …

Upper tract urothelial carcinoma: A rare malignancy with distinct immuno-genomic features in the era of precision-based therapies

K Evmorfopoulos, L Mitrakas, A Karathanasis, I Zachos… - Biomedicines, 2023 - mdpi.com
Upper tract urothelial carcinoma (UTUC) is a rare malignancy, occurring in 5–10% of
patients diagnosed with UC, and involves the renal pelvis, calyces, or ureters. UTUC can be …

Induction and maintenance adjuvant mitomycin C topical therapy for upper tract urothelial carcinoma: tolerability and intermediate term outcomes

M Metcalfe, G Wagenheim, L Xiao… - Journal of …, 2017 - liebertpub.com
Purpose: Endoscopic management of upper tract urothelial carcinoma (UTUC) is associated
with higher recurrences, which could be reduced by application of topical therapy. Adjuvant …

Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes

F Audenet, O Traxer, K Bensalah, M Rouprêt - World journal of urology, 2013 - Springer
Objectives The role of topical upper urinary tract instillation as adjuvant treatment after
conservative management of urothelial carcinomas remains unclear. The aim of this article …

[HTML][HTML] Why are upper tract urothelial carcinoma two different diseases?

T Szarvas, O Módos, A Horváth… - … Andrology and Urology, 2016 - ncbi.nlm.nih.gov
In the last few years growing evidence highlighted the differences between upper tract
urothelial carcinoma (UTUC) and urothelial bladder carcinoma (UBC) which cannot be …

Nephron-sparing approaches in upper tract urothelial carcinoma: current and future strategies

WS Ham, JS Park, WS Jang, J Kim - Biomedicines, 2022 - mdpi.com
Upper tract urothelial carcinoma (UTUC) is a relatively rare cancer, and much of the
approach to treatment has been derived from strategies employed in treating bladder …

Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma

EM Raymundo, ME Lipkin, LB Banez… - Journal of …, 2011 - liebertpub.com
Introduction: Upper tract urothelial carcinoma (UT-UC) is an uncommon disease with
pronounced difference in 5-year survival for noninvasive (96%) versus invasive (17%) …

Outcomes of Intrarenal Bacillus Calmette-Guérin/Interferon-α2B for Biopsy-Proven Upper-Tract Carcinoma in Situ

EY Shapiro, MJ Lipsky, DY Cha… - Journal of …, 2012 - liebertpub.com
Abstract Background and Purpose: While nephroureterectomy (NU) remains the gold-
standard treatment for upper-tract carcinoma in situ (UT-CIS), it may be unnecessarily …